Cbolesterol regarding Preventive healthcare intake Anti-fungal medications 1 in all trials I, Cholestreol, III and IV indicated that maximum feed intake was recorded in T 1 group control drink. This Issue. The antihyperglycemic effect of green tea may be due to activated uptake of glucose, inhibited intestinal glucose transporter and decreased expression of gluconeogenesis controlling genes [ 30 ].

EGCG and cholesterol levels -

PLUS, the latest news on medical advances and breakthroughs from Harvard Medical School experts. Sign up now and get a FREE copy of the Best Diets for Cognitive Fitness. Stay on top of latest health news from Harvard Medical School. Recent Blog Articles. Flowers, chocolates, organ donation — are you in?

What is a tongue-tie? What parents need to know. Which migraine medications are most helpful? How well do you score on brain health? Shining light on night blindness.

Can watching sports be bad for your health? Beyond the usual suspects for healthy resolutions. December 1, Here's what studies have revealed about this popular beverage. What the evidence shows A number of studies have looked at possible links between green tea and cardiovascular disease.

The bottom line "The limited data available on green tea support a potential association between green tea and beneficial properties in relationship to risk factors for cardiovascular disease," says Kathy McManus, director of the department of nutrition at Brigham and Women's Hospital.

Share This Page Share this page to Facebook Share this page to Twitter Share this page via Email. Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol LDL-C : a randomised, double-blind, and cross-over placebo-controlled clinical trial.

BMC Complement Altern Med. Kafeshani M, Entezari MH, Karimian J, Pourmasoumi M, Maracy MR, Amini MR, Hadi A. A comparative study of the effect of green tea and sour tea on blood pressure and lipid profile in healthy adult men.

ARYA Atheroscler. Lee TM, Charng MJ, Tseng CD, Lai LP. A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of STA-2 green tea polyphenols in patients with chronic stable angina.

Acta Cardiol Sin. Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.

PLoS One. Lu PH, Hsu CH. Does supplementation with green tea extract improve acne in post-adolescent women? Complement Ther Med.

Maki KC, Reeves MS, Farmer M, Yasunaga K, Matsuo N, Katsuragi Y, Komikado M, Tokimitsu I, Wilder D, Jones F, et al.

Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J.

Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I. Effects of dietary supplementation with epigallocatechingallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.

Miyazaki R, Kotani K, Ayabe M, Tsuzaki K, Shimada J, Sakane N, Takase H, Ichikawa H, Yonei Y, Ishii K. Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial.

Geriatr Gerontol Int. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity Silver Spring. Nagao T, Meguro S, Hase T, Otsuka K, Komikado M, Tokimitsu I, Yamamoto T, Yamamoto K.

A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Nantz MP, Rowe CA, Bukowski JF, Percival SS. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study.

Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, Meinders AE, Pijl H. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol. Samavat H, Newman AR, Wang R, Yuan JM, Wu AH, Kurzer MS.

Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial. Sone T, Kuriyama S, Nakaya N, Hozawa A, Shimazu T, Nomura K, Rikimaru S, Tsuji I.

Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res. Suliburska J, Bogdanski P, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A. Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients.

Biol Trace Elem Res. Tadayon M, Movahedi S, Abedi P, Syahpoosh A. Impact of green tea extract on serum lipid of postmenopausal women: a randomized controlled trial. J Tradit Complement Med. Venkatakrishnan K, Chiu HF, Cheng JC, Chang YH, Lu YY, Han YC, Shen YC, Tsai KS, Wang CK.

Comparative studies on the hypolipidemic, antioxidant and hepatoprotective activities of catechin-enriched green and oolong tea in a double-blind clinical trial. Food Funct. Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, Pike MC. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women.

Cancer Prev Res Phila. Cao SY, Zhao CN, Gan RY, Xu XY, Wei XL, Corke H, Atanasov AG, Li HB. Effects and mechanisms of tea and its bioactive compounds for the prevention and treatment of cardiovascular diseases: an updated review.

Antioxidants Basel. Cheng H, Xu N, Zhao W, Su J, Liang M, Xie Z, Wu X, Li Q. Mol Nutr Food Res. Wang W, Zhang ZZ, Wu Y, Wang RQ, Chen JW, Chen J, Zhang Y, Chen YJ, Geng M, Xu ZD, et al. Front Pharmacol. Suzuki-Sugihara N, Kishimoto Y, Saita E, Taguchi C, Kobayashi M, Ichitani M, Ukawa Y, Sagesaka YM, Suzuki E, Kondo K.

Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans.

Bursill CA, Roach PD. Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem. Expert Panel on Detection E. Treatment of high blood cholesterol in a: executive summary of the third report of the National Cholesterol Education Program NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults adult treatment panel III.

Giggey PP, Wendell CR, Zonderman AB, Waldstein SR. Greater coffee intake in men is associated with steeper age-related increases in blood pressure. Am J Hypertens. Potter JF, Haigh RA, Harper GD, Fotherby M, Hurd S, Macdonald IA. Blood pressure, plasma catecholamine and renin responses to caffeine in elderly hypertensives.

J Hum Hypertens. Gasinska A, Gajewska D. Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones. Rocz Panstw Zakl Hig. Download references. The present study was supported by the National Natural Science Foundation of China No.

You can also search for this author in PubMed Google Scholar. RFX searched databases, selected studies, extracted data, analyzed data and wrote the manuscript. KY searched databases and selected studies.

SL extracted data. MYD reviewed and edited the manuscript. GZC analyzed data, contributed to the design and discussion, reviewed and edited the manuscript. All authors read and approved the final manuscript. Correspondence to Guangzhi Chen.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Funnel plot of green tea supplementation and total cholesterol.

Funnel plot of green tea supplementation and LDL cholesterol. Funnel plot of green tea supplementation and HDL cholesterol. funnel plot of green tea supplementation and triglyceride. Open Access This article is licensed under a Creative Commons Attribution 4.

The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Reprints and permissions. Xu, R. et al. Effect of green tea consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr J 19 , 48 Download citation. Received : 09 October Accepted : 22 April Published : 16 September Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search. Download PDF. Download ePub. Abstract Background Strong epidemiologic evidence indicates that green tea intake is protective against hyperlipidemia; however, randomized controlled studies have presented varying results.

Methods PubMed, Embase, and the Cochrane Library were electronically explored from inception to September for all relevant studies. Results Thirty-one trials with a total of subjects were included in the meta-analysis. Introduction Cardiovascular diseases CVDs are the leading cause of mortality and disability worldwide, accounting for approximately Assessment of risk of bias in included studies Two authors CGZ and XRF independently assessed the risk of bias of each study, using the Cochrane tool for assessing risk of bias [ 18 ].

Data extraction We extracted all data using a standardized data collection form. Statistical analysis We performed this meta-analysis by using STATA statistical software version 11; STATA Corp LP.

Results Results of the literature search The detailed process of the study selection is depicted in Fig. Full size image. Table 1 Characteristics of 31 included randomized controlled trials Full size table. Table 2 Subgroup analyses of mean change in total cholesterol, LDL cholesterol, HDL cholesterol and triglyceride Full size table.

Discussion The present meta-analysis evaluated the association between green tea consumption and reduction in serum lipid concentrations based on published results from 31 studies comprising subjects. Availability of data and materials All data generated or analyzed during this study are included in this published article.

Abbreviations BP: Blood pressure CIs: Confidence intervals CVDs: Cardiovascular diseases TC: Total cholesterol LDL: Low-density lipoprotein HDL: High-density lipoprotein EGCG: Epigallocatechin gallate EC: Epicatechin EGC: Epigallocatechin ECG: Epicatechingallate GTE: Green tea extracts MDs: Mean differences PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses RCTs: Randomized placebo-controlled trials SD: Standard Deviation SE: Standard error WMD: Weighted mean differences.

References Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. PubMed Google Scholar Jain KS, Kathiravan MK, Somani RS, Shishoo CJ. CAS PubMed Google Scholar Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al.

PubMed Google Scholar Writing Group M, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, et al. Google Scholar Last AR, Ference JD, Menzel ER. PubMed Google Scholar Hunter PM, Hegele RA.

CAS PubMed Google Scholar Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. CAS PubMed Google Scholar Imai K, Nakachi K. CAS PubMed PubMed Central Google Scholar Khan N, Mukhtar H.

CAS PubMed PubMed Central Google Scholar Oz HS, Chen T, de Villiers WJ. PubMed PubMed Central Google Scholar Klaus S, Pultz S, Thone-Reineke C, Wolfram S. CAS Google Scholar Xing L, Zhang H, Qi R, Tsao R, Mine Y. CAS PubMed Google Scholar Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH.

CAS PubMed Google Scholar Alves Ferreira M, Oliveira Gomes AP, Guimaraes de Moraes AP, Ferreira Stringhini ML, Mota JF, Siqueira Guedes Coelho A, Borges Botelho P. In the group treated with 0. Total fat absorption was very efficient in the control group This study provides evidence suggesting that the cholesterol-lowering effect of green tea is mainly elicited by EGCG, one of the most abundant catechins contained in green tea.

New cholesteroll shows little risk of infection lvels Anti-fungal medications cholesteril. Discrimination at Preventive healthcare is linked to high Preventive healthcare pressure. Levsls fingers and toes: Poor circulation or Raynaud's phenomenon? Lowering your risk of cardiovascular disease may be as easy as drinking green tea. Studies suggest this light, aromatic tea may lower LDL cholesterol and triglycerides, which may be responsible for the tea's association with reduced risk of death from heart disease and stroke. Black tea had no effect on heart risk. Nutrition Journal volume 19Article Diabetes and the elderly population 48 Cite this article. Metrics details. Strong epidemiologic evidence levwls that green Preventive healthcare intake is protective EGCG and cholesterol levels hyperlipidemia; Anti-fungal medications, leveels controlled amd have presented varying results. In the present study, we aimed to conduct a literature review and meta-analysis to assess the effect of green tea on blood lipids. PubMed, Embase, and the Cochrane Library were electronically explored from inception to September for all relevant studies. The risk of bias for study was assessed using the Cochrane tool.

Video

STOP Drinking Tea Until You Watch This